Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Techniclone initiates phase I/II trial of TNT for solid tumors, reports phase I brain cancer results

May 27, 1999

MGI Pharma expands ovarian cancer trial with MGI-114

May 27, 1999

ASCO news: Abgenix presents preclinical pharmacological profile of fully human anti-EGF MAb

May 26, 1999

Cancer vaccine induces disease stabilization and is well tolerated in ongoing early clinical trials

May 26, 1999

Joint effort at Zeneca and Isis results in preparation of TS mRNA-targeting ODNs

May 26, 1999

BPHA: a potent and selective MMP inhibitor in early development at Shionogi

May 26, 1999

C225 demonstrates high efficacy and good tolerance in two types of carcinomas

May 25, 1999

SkyePharma announces U.S. launch of DepoCyt

May 25, 1999

Corixa, Zambon collaborate to develop lung cancer immunotherapeutic vaccines

May 25, 1999

K1-5 is a more potent angiogenesis inhibitor than angiostatin

May 25, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...